Amedeo Smart

Free Medical Literature Service

 

Amedeo

COVID-19
  Free Subscription

01.08.2022

1 Acad Emerg Med
3 Am J Respir Crit Care Med
2 Ann Intern Med
6 BMJ
3 Clin Chem
4 Clin Infect Dis
1 Emerg Infect Dis
6 Int J Infect Dis
3 J Infect
8 J Med Virol
4 J Travel Med
2 J Virol
5 JAMA
1 MMWR Morb Mortal Wkly Rep
5 Nature
2 Pol J Radiol
2 Science


    Acad Emerg Med

  1. JACOBS BB, Manfredi RA
    More silver linings of the COVID pandemic: Uplifting effects continue.
    Acad Emerg Med. 2022;29:918-920.
    >> Share


    Am J Respir Crit Care Med

  2. MANG S, Wengenmayer T, Danziger G, Muellenbach RM, et al
    Extracorporeal Membrane Oxygenation Transport for Severe COVID-19 - Why We Can and Should!
    Am J Respir Crit Care Med. 2022 Jul 26. doi: 10.1164/rccm.202207-1305.
    >> Share

  3. GANNON WD, Stokes JW, Francois SA, Patel YJ, et al
    Reply to: Extracorporeal membrane oxygenation transport for severe COVID-19 - why we can and should!
    Am J Respir Crit Care Med. 2022 Jul 26. doi: 10.1164/rccm.202207-1415.
    >> Share

  4. PETTENUZZO T, Sella N, Lorenzoni G, Calore A, et al
    The Recruitment-to-Inflation Ratio is Correlated with EIT-Derived Collapse and Overdistention in COVID-19 ARDS.
    Am J Respir Crit Care Med. 2022 Jul 23. doi: 10.1164/rccm.202203-0555.
    >> Share


    Ann Intern Med

  5. CHOU R, Dana T, Jungbauer R
    Update Alert 8: Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings.
    Ann Intern Med. 2022 Jul 26. doi: 10.7326/L22-0272.
    >> Share

  6. CANTOR AG, Jungbauer RM, Totten AM, Tilden EL, et al
    Telehealth Strategies for the Delivery of Maternal Health Care : A Rapid Review.
    Ann Intern Med. 2022 Jul 26. doi: 10.7326/M22-0737.
    >> Share


    BMJ

  7. DE FOO C, Haldane V, Jung AS, Grepin KA, et al
    Isolation facilities for covid-19: towards a person centred approach.
    BMJ. 2022;378:e069558.
    >> Share

  8. DAVIES MW
    Learning from complaints during covid-19: discuss risks and benefits before hospital treatment.
    BMJ. 2022;378:o1858.
    >> Share

  9. DYER C
    Covid-19: "Impossible" to be confident that government awarded Randox contracts properly, say MPs.
    BMJ. 2022;378:o1893.
    >> Share

  10. TAN BKJ, Han R, Zhao JJ, Tan NKW, et al
    Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis with parametric cure modelling of recovery curves.
    BMJ. 2022;378:e069503.
    >> Share

  11. KYE WEN TAN N, Jing-Wen C, Tan, Kye Jyn Tan B, et al
    The burden of prolonged smell and taste loss in covid-19.
    BMJ. 2022;378:o1895.
    >> Share

  12. SAXENA S, Skirrow H, Wighton K
    Vaccinating children aged under 5 years against covid-19.
    BMJ. 2022;378:o1863.
    >> Share


    Clin Chem

  13. BULARGA A, Oskoui E, Fujisawa T, Jenks S, et al
    Macrotroponin Complex as a Cause for Cardiac Troponin Increase after COVID-19 Vaccination and Infection.
    Clin Chem. 2022;68:1015-1019.
    >> Share

  14. KAVSAK PA
    Commentary on Macrotroponin Complex as a Cause for Cardiac Troponin Increase after COVID-19 Vaccination and Infection.
    Clin Chem. 2022;68:1019-1020.
    >> Share

  15. CROAL B
    Commentary on Macrotroponin Complex as a Cause for Cardiac Troponin Increase after COVID-19 Vaccination and Infection.
    Clin Chem. 2022;68:1020-1021.
    >> Share


    Clin Infect Dis

  16. MALAHE SRK, Hoek RAS, Dalm VASH, Broers AEC, et al
    Clinical characteristics and outcome of immunocompromised patients with COVID-19 caused by the Omicron variant: a prospective observational study.
    Clin Infect Dis. 2022 Jul 23. pii: 6649068. doi: 10.1093.
    >> Share

  17. ESPARCIA-PINEDO L, Yarci-Carrion A, Mateo-Jimenez G, Ropero N, et al
    Development of an effective immune response in adults with Down Syndrome after SARS-CoV-2 vaccination.
    Clin Infect Dis. 2022 Jul 23. pii: 6649074. doi: 10.1093.
    >> Share

  18. LI H, Gao M, You H, Zhang P, et al
    Association of nirmatrelvir/ritonavir treatment on upper respiratory SARS-CoV-2 RT-PCR negative conversion rates among high-risk patients with COVID-19.
    Clin Infect Dis. 2022 Jul 23. pii: 6649232. doi: 10.1093.
    >> Share

  19. LEHRNBECHER T, Sack U, Speckmann C, Groll AH, et al
    Longitudinal Immune Response to Three Doses of mRNA Vaccine Against COVID-19 in Pediatric Patients Receiving Chemotherapy for Cancer.
    Clin Infect Dis. 2022 Jul 28. pii: 6651274. doi: 10.1093.
    >> Share


    Emerg Infect Dis

  20. BERTRAN M, Amin-Chowdhury Z, Sheppard CL, Eletu S, et al
    Increased Incidence of Invasive Pneumococcal Disease among Children after COVID-19 Pandemic, England.
    Emerg Infect Dis. 2022;28:1669-1672.
    >> Share


    Int J Infect Dis

  21. AIELLO A, Coppola A, Vanini V, Petrone L, et al
    Accuracy of QuantiFERON SARS-CoV-2 RUO assay and characterization of the CD4(+) and CD8(+) T-cell-SARS-CoV-2 response: comparison with a homemade IFN-gamma release assay.
    Int J Infect Dis. 2022 Jul 22. pii: S1201-9712(22)00444.
    >> Share

  22. DORIA G, Clemente C, Coelho E, Colaco J, et al
    An isothermal lab-on-phone test for easy molecular diagnostic of SARS-CoV-2 near patient and in less than 1 hour.
    Int J Infect Dis. 2022 Jul 22. pii: S1201-9712(22)00436.
    >> Share

  23. VALLADARES-GARRIDO MJ, Failoc-Rojas VE, Soto-Becerra P, Zena-Nanez S, et al
    Clinical-epidemiological variation in patients treated in the first and second wave of COVID-19 in Lambayeque, Peru: A cluster analysis.
    Int J Infect Dis. 2022 Jul 21. pii: S1201-9712(22)00442.
    >> Share

  24. VILLAFUERTE DB, Lavrynenko O, Qazi R, Passeri MF, et al
    Chronic Active Epstein-Barr Exacerbated by COVID-19 Co-Infection.
    Int J Infect Dis. 2022 Jul 21. pii: S1201-9712(22)00439.
    >> Share

  25. AKHMETZHANOV AR, Ponce L, Thompson RN
    Emergence potential of Monkeypox in the Western Pacific Region, July 2022.
    Int J Infect Dis. 2022 Jul 21. pii: S1201-9712(22)00441.
    >> Share

  26. LU J, Zhu J, Zhu J, Duong TQ, et al
    LSTM machine learning of longitudinal clinical data accurately predicts acute kidney injury onset in COVID-19: a two-center study.
    Int J Infect Dis. 2022 Jul 21. pii: S1201-9712(22)00429.
    >> Share


    J Infect

  27. FU J, Luo Y, Fang X, Lu J, et al
    Genetic variation of Golgi membrane protein 1 is associated with COVID-19 disease.
    J Infect. 2022 Jul 22. pii: S0163-4453(22)00420.
    >> Share

  28. VELLAS C, Kamar N, Izopet J
    Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatment.
    J Infect. 2022 Jul 22. pii: S0163-4453(22)00422.
    >> Share

  29. LI M, Luo Q, Gong C, Li AH, et al
    Prospective Surveillance of Human Adenovirus in Acute Respiratory Infections Reveals Epidemiological Features and the Disappearance of Species B During the COVID-19 Pandemic in Beijing, China.
    J Infect. 2022 Jul 22. pii: S0163-4453(22)00423.
    >> Share


    J Med Virol

  30. LIU R, Lin X, Chen B, Hou Z, et al
    The mutation features and geographical distributions of the surface glycoprotein (S gene) in SARS-CoV-2 strains: a comparative analysis of the early and current strains.
    J Med Virol. 2022 Jul 24. doi: 10.1002/jmv.28023.
    >> Share

  31. DU Y, Li W, Guo Y, Li L, et al
    Epidemiology and genetic characterization of human metapneumovirus in pediatric patients from Hangzhou China.
    J Med Virol. 2022 Jul 24. doi: 10.1002/jmv.28024.
    >> Share

  32. WANG X, Zhao X, Cui Y, Qiao R, et al
    Neutralization of Distinct Omicron Sublineages by Longitudinal Vaccination Sera.
    J Med Virol. 2022 Jul 22. doi: 10.1002/jmv.28017.
    >> Share

  33. PENG H, Zheng B, Yang S, Du J, et al
    A soluble DR5-Fc chimeric protein (sDR5-Fc) attenuates inflammatory responses induced by coronavirus MHV-A59 and SARS-CoV-2.
    J Med Virol. 2022 Jul 22. doi: 10.1002/jmv.28021.
    >> Share

  34. BAUER G, Struck F, Staschik E, Maile J, et al
    Differential avidity determination of IgG directed towards the receptor-binding domain (RBD) of SARS-CoV-2 wild-type and its variants in one assay: Rational tool for the assessment of protective immunity.
    J Med Virol. 2022 Jul 18. doi: 10.1002/jmv.28006.
    >> Share

  35. JANG EJ, Choe YJ, Yun GW, Wang S, et al
    Reinfection with SARS-CoV-2 in general population, South Korea; nationwide retrospective cohort study.
    J Med Virol. 2022 Jul 25. doi: 10.1002/jmv.28026.
    >> Share

  36. POURAKBARI B, Mirbeyk M, Mahmoudi S, Sadeghi RH, et al
    Evaluation of response to different COVID-19 vaccines in vaccinated healthcare workers in a single center in Iran.
    J Med Virol. 2022 Jul 26. doi: 10.1002/jmv.28029.
    >> Share

  37. KOJIMA N, Desai V, Klausner JD
    Distributing Effective SARS-CoV-2 Medicines in a Timely Manner.
    J Med Virol. 2022 Jul 26. doi: 10.1002/jmv.28030.
    >> Share


    J Travel Med

  38. VINCETI M, Balboni E, Rothman KJ, Teggi S, et al
    Substantial impact of mobility restrictions on reducing COVID-19 incidence in Italy in 2020.
    J Travel Med. 2022 Jul 24. pii: 6649390. doi: 10.1093.
    >> Share

  39. NORMAN FF, Trevino-Maruri B, Giardin JMR, Gullon-Pena B, et al
    Trends in Imported Malaria during the COVID-19 pandemic, Spain (+Redivi Collaborative Network).
    J Travel Med. 2022 Jul 24. pii: 6649393. doi: 10.1093.
    >> Share

  40. HAN C, Ryu S, Shin H, Kim D, et al
    Impact of national lockdown on the suspected SARS-CoV-2 epidemic in terms of the number of fever cases in North Korea.
    J Travel Med. 2022 Jul 28. pii: 6651005. doi: 10.1093.
    >> Share

  41. KUMAR NP, Banurekha VV, Kumar CPG, Nancy A, et al
    Covaxin induced antibody responses.
    J Travel Med. 2022 Jul 28. pii: 6651027. doi: 10.1093.
    >> Share


    J Virol

  42. FROLOVA EI, Palchevska O, Lukash T, Dominguez F, et al
    Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.
    J Virol. 2022 Jul 25:e0075322. doi: 10.1128/jvi.00753.
    >> Share

  43. DONG S, Kong N, Wang C, Li Y, et al
    FUBP3 Degrades the Porcine Epidemic Diarrhea Virus Nucleocapsid Protein and Induces the Production of Type I Interferon.
    J Virol. 2022;96:e0061822.
    >> Share


    JAMA

  44. ZENG G
    SARS-CoV-2 Omicron Variant Severity in Ontario, Canada.
    JAMA. 2022;328:395.
    >> Share

  45. ULLOA AC, Buchan SA, Brown KA
    SARS-CoV-2 Omicron Variant Severity in Ontario, Canada-Reply.
    JAMA. 2022;328:395-396.
    >> Share

  46. SLOMSKI A
    Evusheld Reduces COVID-19 Disease Severity Among Unvaccinated Adults.
    JAMA. 2022;328:322.
    >> Share

  47. KUEHN BM
    Persistent Disparities in COVID-19 Antiviral Dispensing.
    JAMA. 2022;328:323.
    >> Share

  48. MALANI AG, Malani AN
    Preventive Medication for COVID-19 Infection.
    JAMA. 2022 Jul 25. pii: 2794799. doi: 10.1001/jama.2022.13214.
    >> Share


    MMWR Morb Mortal Wkly Rep

  49. HAUSE AM, Baggs J, Marquez P, Abara WE, et al
    Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged >/=50 Years - United States, March 29, 2022-July 10, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:971-976.
    >> Share


    Nature

  50. KARAGIANNIS F, Peukert K, Surace L, Michla M, et al
    Impaired ketogenesis ties metabolism to T cell dysfunction in COVID-19.
    Nature. 2022 Jul 28. pii: 10.1038/s41586-022-05128.
    >> Share

  51. ADAM D
    How long is COVID infectious? What scientists know so far.
    Nature. 2022 Jul 26. pii: 10.1038/d41586-022-02026.
    >> Share

  52. YE Y
    China approves first homegrown COVID antiviral.
    Nature. 2022 Jul 26. pii: 10.1038/d41586-022-02050.
    >> Share

  53. GUGLIELMI G
    Pandemic drives largest drop in childhood vaccinations in 30 years.
    Nature. 2022 Jul 26. pii: 10.1038/d41586-022-02051.
    >> Share


  54. Monkeypox: wealthy countries must avoid their COVID-19 mistakes.
    Nature. 2022;607:635-636.
    >> Share


    Pol J Radiol

  55. DESHMUKH YA, Vaid S, Chandorkar A, Atre A, et al
    Imaging spectrum of rhino-orbital-cerebral mucormycosis secondary to COVID-19 infection: a reporting checklist.
    Pol J Radiol. 2022;87:e333-e347.
    >> Share

  56. SAMKOWSKI J, Sklinda K, Walecki JM
    Lymphadenopathy in the era of COVID-19 vaccination - an oncological dilemma in diagnostic imaging.
    Pol J Radiol. 2022;87:e304-e310.
    >> Share


    Science

  57. PEKAR JE, Magee A, Parker E, Moshiri N, et al
    The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2.
    Science. 2022 Jul 26:eabp8337. doi: 10.1126/science.abp8337.
    >> Share

  58. WOROBEY M, Levy JI, Serrano LM, Crits-Christoph A, et al
    The Huanan Seafood Wholesale Market in Wuhan was the early epicenter of the COVID-19 pandemic.
    Science. 2022 Jul 26:abp8715. doi: 10.1126/science.abp8715.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016